major
surgery
classic
hemophilia
using
fraction
i
experience
twelve
operations
review
literature
a
therapeutic
regimen
provides
hemostasis
hemophiliacs
major
surgery
without
requiring
laboratory
control
established
a
factor
viii
concentrate
effectiveness
regimen
fraction
i
therapy
evaluated
major
surgery
severely
deficient
moderately
deficient
hemophiliacs
analysis
clinical
results
made
combining
operations
series
major
operative
procedures
hemophiliacs
recorded
english
literature
fraction
i
sole
major
source
factor
viii
therapy
dental
nondental
surgery
analyzed
separately
special
problem
blood
cysts
although
overall
mortality
rate
following
major
surgery
hemophiliacs
presently
using
factor
viii
concentrates
problems
still
remain
include
continued
high
incidence
abnormal
postoperative
hemorrhage
variation
factor
viii
potency
different
lots
fraction
i
late
development
serum
hepatitis
hemolytic
anemia
due
contaminating
isoantibodies
high
cost
adequate
amounts
product
efficient
methods
preparing
purer
potent
factor
viii
concentrates
could
eliminate
difficulties
